Castle Biosciences's total assets for Q3 2024 were $514.57M, an increase of 5.59% from the previous quarter. CSTL total liabilities were $73.51M for the fiscal quarter, a 15.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.